We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
The coronavirus vaccine developed by Pfizer and BioNTech was found to have a 95 percent success rate in trial participants. Health Secretary Matt Hancock said the UK Government has already asked the medicine regulator in the country to assess the suitability of the vaccine for a potential authorisation before December. Mr Hancock said: “Pfizer/BioNTech announced this morning that it has submitted for emergency use authorisation from the FDA based on phase-3 data that shows the vaccine is 95 percent effective with no serious safety concerns.
“Here in the UK, the first step of authorising the vaccine is for the Government to ask the independent regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) to assess its suitability.
“The MHRA, which acts for the entire UK, is one of the most respected regulators and I can confirm the Government has asked the MHRA to assess the Pfizer/BioNTech vaccine for its suitability for authorisation.”
Mr Hancock continued: “This is another important step forward in tackling this pandemic.
“If a vaccine is approved, it will, of course, be available across the UK from our NHS, free at the point of delivery, according to need not ability to pay.
JUST IN: Coronavirus vaccine plan LEAKED: NHS paper shows jab roll-out date for EACH age range
“We’ve procured vaccines on behalf of all parts of our country and I’m working with the devolved administrations to ensure it’s devolved fairly to all across the UK. We will prioritise groups who are at greatest risk.”
More to follow…
Source: Read Full Article